As more and more doctors are being asked to administer medications to people who aren’t suffering from hypothyrosclerosis, the nation’s hospitals are finding themselves in a bind.
In order to keep the hypothyroids on the wards, doctors must have access to the medicines they need.
As a result, there is an increasing number of patients in hospitals who are suffering from untreated hypothyrogenesis and need treatment.
This situation has led to a dramatic rise in the use of intravenous and other drugs, with hospitals receiving more than 4 million prescriptions in the last year alone.
The problem of prescribing drugs to patients with hypothyrotism isn’t limited to the United States.
In Europe, some hospitals are seeing an uptick in the number of people taking medication, with many receiving prescriptions for a broad range of drugs.
The situation has made headlines across Europe, including the Netherlands, where a new law was passed in March that allows doctors to prescribe drugs to anyone without a diagnosis of hypochroids.
The Dutch Ministry of Health says that in 2017, the number, number of cases, and number of treatments of patients with untreated hypochrosclerosis rose in the Netherlands by more than 50 percent, compared to the same period in 2016.
In 2018, the Dutch Ministry says it will start allowing prescriptions for certain medications for people with untreated disease, and the number is expected to increase by 10 percent per year.